Hubei Goto Biopharm Co P/E 2024

Hubei Goto Biopharm Co P/E

86.03

Hubei Goto Biopharm Co Dividend yield

0.7 %

Ticker

300966.SZ

ISIN

CNE100004K94

As of May 19, 2024, Hubei Goto Biopharm Co's P/E ratio was 86.03, a 0.62% change from the 85.5 P/E ratio recorded in the previous year.

The Hubei Goto Biopharm Co P/E history

Hubei Goto Biopharm Co Aktienanalyse

What does Hubei Goto Biopharm Co do?

Hubei Goto Biopharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Hubei Goto Biopharm Co's P/E Ratio

The Price to Earnings (P/E) Ratio of Hubei Goto Biopharm Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Hubei Goto Biopharm Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Hubei Goto Biopharm Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Hubei Goto Biopharm Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Hubei Goto Biopharm Co Stock

What is the price-to-earnings ratio of Hubei Goto Biopharm Co?

The price-earnings ratio of Hubei Goto Biopharm Co is currently 86.03.

How has the price-earnings ratio of Hubei Goto Biopharm Co changed compared to last year?

The price-to-earnings ratio of Hubei Goto Biopharm Co has increased by 0.62% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Hubei Goto Biopharm Co high compared to other companies?

Yes, the price-to-earnings ratio of Hubei Goto Biopharm Co is high compared to other companies.

How does an increase in the price-earnings ratio of Hubei Goto Biopharm Co affect the company?

An increase in the price-earnings ratio of Hubei Goto Biopharm Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Hubei Goto Biopharm Co affect the company?

A decrease in the price-earnings ratio of Hubei Goto Biopharm Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Hubei Goto Biopharm Co?

Some factors that influence the price-earnings ratio of Hubei Goto Biopharm Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Hubei Goto Biopharm Co pay?

Over the past 12 months, Hubei Goto Biopharm Co paid a dividend of 0.14 CNY . This corresponds to a dividend yield of about 0.7 %. For the coming 12 months, Hubei Goto Biopharm Co is expected to pay a dividend of 0.14 CNY.

What is the dividend yield of Hubei Goto Biopharm Co?

The current dividend yield of Hubei Goto Biopharm Co is 0.7 %.

When does Hubei Goto Biopharm Co pay dividends?

Hubei Goto Biopharm Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hubei Goto Biopharm Co?

Hubei Goto Biopharm Co paid dividends every year for the past 1 years.

What is the dividend of Hubei Goto Biopharm Co?

For the upcoming 12 months, dividends amounting to 0.14 CNY are expected. This corresponds to a dividend yield of 0.7 %.

In which sector is Hubei Goto Biopharm Co located?

Hubei Goto Biopharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hubei Goto Biopharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hubei Goto Biopharm Co from 5/31/2022 amounting to 0.136 CNY, you needed to have the stock in your portfolio before the ex-date on 5/31/2022.

When did Hubei Goto Biopharm Co pay the last dividend?

The last dividend was paid out on 5/31/2022.

What was the dividend of Hubei Goto Biopharm Co in the year 2023?

In the year 2023, Hubei Goto Biopharm Co distributed 0 CNY as dividends.

In which currency does Hubei Goto Biopharm Co pay out the dividend?

The dividends of Hubei Goto Biopharm Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hubei Goto Biopharm Co

Our stock analysis for Hubei Goto Biopharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hubei Goto Biopharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.